HealthQuill Articles by: HealthQuill
AstraZeneca has stopped an end-phase trial for its experimental lung cancer drug, volrustomig, after data showed the combination therapy failed to outperform standard treatments for advanced non-small cell lung cancer.
Drugs Health Pharma

AstraZeneca ends late-stage trial of drug to treat non-small cell cancer

HQ Team August 17, 2026: AstraZeneca has stopped an end-phase trial for its experimental lung cancer drug, volrustomig, after data showed the combination

Read More
An outbreak of the Bundibugyo species of Ebola, which has no approved vaccines or treatments, has killed 2,325 people, becoming the deadliest in the central African country of the Democratic Republic of Congo.
Drugs Health Medical

Ebola virus becomes deadliest outbreak in Congo, still ‘moving fast’

HQ Team August 17, 2026: An outbreak of the Bundibugyo species of Ebola, which has no approved vaccines or treatments, has killed 2,325

Read More
Novo Nordisk A/S’s data from a clinical trial of a weight-loss medicine, treating overweight and obese adult participants, showed patients lost about 23% of their body weight compared to a dummy group’s 2-3%.
Health

GLP-1 drugs may stop early-stage cancers from spreading

HQ Team July 28, 2026: People taking GLP-1 drugs (glucagon-like peptide-1 receptor agonists, the same class as Ozempic and Wegovy) for diabetes alongside

Read More
Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of the Covid-19 virus to contribute to their persistence and recurrence of the infection, a study finds.
Drugs

1 in 6 people rate bad primary care as “fine”, reveals 18-country survey

HQ Team July 24, 2026: Nearly one in six people surveyed across 18 countries rated a textbook case of poor primary care, including

Read More
nasal spray
Drugs

Eli Lilly spent $3.8 billion on psychedelics. Here’s the reason why

HQ Team July 23, 2026: Eli Lilly, the pharma company behind weight-loss blockbusters Mounjaro and Zepbound recently agreed to buy AtaiBeckley, a psychedelic

Read More
The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.
Drugs

Health benefits hype drive FDA to review 7 peptides and their sale

HQ Team July 23, 2026: Peptides, the short chains of amino acids that serve as the building blocks of proteins, are generating significant

Read More
Global health bodies in more than 100 nations are uniting to vaccinate children after COVID-19 waves severed supplies, shuttered clinics, and overburdened health services.
Drugs Health

US measles cases hit a 35-year high at 2,295

HQ Team July 22, 2026: The United States has recorded 2,295 measles cases,  the highest total in 35 years. The raw number is

Read More
Eli Lilly and Company will acquire SiteOne Therapeutics, Inc. for $1 billion to get access to an inhibitor that may cure chronic pain without using opioids.
Drugs

FDA updated drug labelling regulations guide (2026)

HQ Team July 21, 2026: Every prescription drug sold in the United States carries labelling that the FDA treats as a legal document,

Read More
Eli Lilly will invest an additional $450 million to expand its manufacturing capacity at Research Triangle Park facility in North Carolina.
Pharma

The weight-loss drug race just got crowded

Jay Shankar July 21, 2026: Global obesity medicine sales hit $66 billion in 2025 and are on track to reach $92 billion this

Read More
The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency.
Health Research

Pandemic-born four-year-olds read well but struggle to focus: Study

July18,2026: One in three four-year-olds born during England’s first COVID-19 lockdown is struggling to focus, follow instructions, or manage frustration in the classroom

Read More